Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

June 29, 2020June 29, 2020

Equfina, Known as Xadago in US, Approved in S. Korea as Levodopa Add-on

News

Equfina (safinamide) has been approved in South Korea as an add-on therapy to levodopa for Parkinson’s disease patients who experience “off” episodes, Eisai, which is marketing this medication in ... Read more

June 18, 2020June 18, 2020

Changes in Structure of Alpha-synuclein Seen to Make Protein Prone to Clumping

News

Structural changes within alpha-synuclein can make this protein more prone to clumping — a common feature of Parkinson’s — a research group found, a discovery that might lead to ways of ... Read more

June 9, 2020June 9, 2020

NeuroMotor Pen, Tool for Early Disease Diagnosis, Soon Widely Available

News

Manus Neurodynamica, a medical technology company, has raised £750,000 in a financing round to support the rollout of NeuroMotor Pen, a digital pen with a patented sensor technology to help ... Read more

June 8, 2020June 8, 2020

Gocovri Before FDA as Possible Bedtime Therapy for ‘Off’ Time in Parkinson’s

News

The U.S. Food and Drug Administration (FDA) has agreed to review Adamas Pharmaceutical’s application asking that oral Gocovri (amantadine) also be approved to treat off episodes in Parkinson’s disease patients using levodopa. An FDA ... Read more

June 3, 2020June 3, 2020

Treatments Targeting LRRK2 Not Likely to Damage Organs, Study Finds

News

People carrying gene variants that lower leucine-rich repeat kinase 2 (LRRK2) levels — an enzyme whose mutated form is one of the most common genetic causes of Parkinson’s disease — live as long as those ... Read more

June 1, 2020June 2, 2020

Preclinical Study of SLS-004, Potential Parkinson’s Gene Therapy, Starting

News

Seelos Therapeutics announced it is beginning, earlier than expected, a preclinical study into its investigational gene therapy candidate for Parkinson’s disease called SLS-004. The exact nature of this early research work was not detailed ... Read more

May 18, 2020May 18, 2020

Smokers at Lower Risk of Parkinson’s, Long-term Study Finds

News

Current or past tobacco smokers are at lower risk of developing Parkinson’s disease than lifelong non-smokers, a long-term study of doctors in the U.K. reports. How smoking might protect a person ... Read more

May 7, 2020May 7, 2020

GB Sciences Granted US Patent for Cannabinoid-based Formulations for Parkinson’s

News

GB Sciences has been granted a patent from the U.S. Patent and Trademark Office (USPTO) covering the use of its proprietary cannabinoid-containing complex mixtures for treating Parkinson’s disease, the company ... Read more

May 4, 2020May 5, 2020

New Technology May Boost Efficacy of Potential Gene Therapies for Parkinson’s, Others

News

Researchers have developed short gene promoters — structures that act like switches to turn on genes — that may boost the effectiveness of gene therapies targeting the central nervous ... Read more

April 17, 2020April 20, 2020

Compounds in Chinese Herbal Medicine May Treat Parkinson’s, Study Suggests

News

Zhichan powder, a traditional Chinese medicine, contains several active compounds that may be of therapeutic value in Parkinson’s disease, researchers suggest. Their study, “Network Pharmacology Analysis on Zhichan Powder in ... Read more

Pin It on Pinterest